Gilead licenses HIV-prevention drug to generic drugmakers

How a new HIV medicine reduced carbon emissions

Latin America is catching up on HPV vaccination and screening

Wider use of material-saving HIV drug cutting CO2 emissions: Report

World’s leading HIV drug reduces carbon emissions by 26 million tons In comparison to predecessor

Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

Game-changing HIV shot can’t get to high-risk groups fast enough

HIV trial shows injectable prevents 100% infection in women and girls